Today's noteworthy initiations include: Acadia (ACHC) initiated with an Overweight at KeyBanc... Altisource Residential (RESI) initiated with a Neutral at Nomura... Colony Starwood Homes (SFR) initiated with a Buy at Nomura... EyeGate (EYEG) initiated with a Buy at Rodman & Renshaw... Fortinet (FTNT) initiated with an Outperform at Northland... Halozyme (HALO) initiated with a Buy at Canaccord... Lendingtree (TREE) initiated with an Outperform at Northland... Lindblad Expeditions (LIND) initiated with an Outperform at Credit Suisse... Summit Therapeutics (SMMT) initiated with a Buy at Canaccord... VolitionRx (VNRX) initiated with a Buy at Rodman & Renshaw.

VolitionRx's Nu.Q Vet Cancer Test is now available in-clinic to veterinarians across the U.S and Europe through Antech, a veterinary diagnostics company. Antech's in-clinic version of the Nu.Q Canine Cancer Test operates on the Element i+ Analyzer, providing veterinarians with a cancer screening tool for high-risk breeds and older dogs, at the patient side, with results in about six minutes. Volition's original license and supply agreement was between Belgian Volition SRL and Heska, an Antech company, part of Mars Science & Diagnostics.